OrVance agreed to manage the sales and distribution of DOC Brands’ oral health products while sharing costs and profits.
OrVance, a developer of proprietary oral health products, announced an exclusive licensing agreement with DOC Brands.
DOC Brands is an emerging consumer oral care company manufacturing and selling products marketed under the Dentemp brand.
Under the terms of the agreement between the two companies, DOC Brands will manage all operations, marketing, sales, and distribution of the OrVance products while sharing the costs, expected synergies, and profits generated by the partnership.
“We are very excited to enter this partnership with DOC Brands not only for their strong retail distribution and brand recognition but also because of their passion to grow the consumer oral health segment by bringing real innovation and value to the consumer,” said Ron Schutt, OrVance’s CEO. “OrVance’s current and future products deliver meaningful innovation that advances oral health, so we are confident this venture with DOC Brands is well poised for success.”
David Fox was named to lead the partnership venture as the commercial lead and senior advisor to DOC Brands. Fox is an oral care consumer packaged goods executive with nearly 20 years of experience, including as president and chief executive officer of DenTek Oral Care and general manager/vice president of global oral care at Church & Dwight.
“This partnership with OrVance really strengthens DOC Brands’ oral care product line and our ability to continue to bring retailers and consumers meaningful advancements in consumer oral health,” said Fox. “I’m very impressed by how OrVance has consistently developed proprietary innovation through its consumer research, science, intellectual property, and the engagement of the dental and orthodontic professions.”
Photo courtesy of OrVance
